期刊文献+

人乳头状瘤病毒18型阳性肿瘤疫苗的构建及体外活性鉴定

Construction of human papilloma virus type 18-positive tumor vaccine by Bac to Bac baculovirus expression system and examination of its in vitro activity
下载PDF
导出
摘要 目的:制备人乳头状瘤病毒(human papilloma virus,HPV)18型阳性的肿瘤疫苗,并观察其体外活性。方法:利用昆虫杆状病毒(简称Bac to Bac)表达系统,将HPV18L1基因重组入穿梭质粒pFastBac-Htb,构建HPV18L1-Htb,通过转座反应,将目的基因片段重组入杆状病毒基因组,分离重组的Bacmid DNA,并转染Sf-9昆虫细胞进行表达;透射电镜观察病毒样颗粒(virus-like particle,VLP)的形成;用Ni-NTA系统纯化表达蛋白;以小鼠红细胞凝集试验鉴定蛋白生物活性。结果:收集被转染的Sf-9细胞,提取细胞蛋白,SDS-PAGE检测在相对分子质量大约63000处可出现一新生蛋白条带,Western blotting证实为HPV18L1蛋白;透射电镜观察证实L1蛋白可自我组装成VLP,且主要定位于细胞核;小鼠红细胞凝集试验证实纯化的蛋白在0.5~4ng/μl范围可介导小鼠红细胞凝集。结论:Bac to Bac表达系统可高效地制备HPVVLP,并具有体外生物学活性;Ni-NTA系统能高效简便地纯化带有6×His短肽的HPV18L1蛋白。 Objective: To prepare human papilloma virus type 18 (HPV 18)-positive tumor vaccine and to examine its in vitro activity. Methods: A Bac to Bac expression system was employed in the present study. HPV18L1 gene was inserted into shuttle plasmid pFastBac-Hth to construct HPV18 L1-Htb; the latter was used to transform DH10Bac cells to construct a recombinant baculovirus to infect Sf-9 insect cells. The protein of interest was identified by observing self-assemble into VLPs under transmission electron microscope and was purified by Ni-NTA purification system. The bioactivity of the purified protein was analyzed by mouse erythrocyte hemagglutination assay. Results: The infected Sf-9 cells were collected and total cellular proteins were extracted. SDS-PAGE assay revealed a roughly 63 000 D protein, which was confirmed to be HPV18 L1 by Western blotting. Transmission electron microscope showed that the proteins formed into VLP by self-assemble in vitro and located mainly in the nuclei. It was found that the protein induced mouse erythrocyte hemagglutination. Conclusion: Bac to Bac expression system can effectively prepare HPV VLP with in vitro bioactivity. The Ni-NTA purification system can purify the protein with 6 × His tag efficiently.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2007年第3期220-224,共5页 Chinese Journal of Cancer Biotherapy
基金 国家重点基础研究发展(973)计划资助项目(No2002CB513100) 国家自然科学基金资助项目(No30672227)~~
关键词 人乳头状瘤病毒18型 昆虫杆状病毒表达系统 肿瘤疫苗 human papillomavirus type 18 Bac to Bac baculovirus expression system tumor vaccine
  • 相关文献

参考文献19

  • 1Sanclemente G,Gill DK.Human papillomavirus molecular biology and pathogenesis[J].J Eur Acad Dermatol Venereol,2002,16(3):23l-240. 被引量:1
  • 2Zhou J,Sun XY,Stenzel DJ,et al.Expression of vaccinia recombinant HPV16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles[J].Virology,1991,185(1):251-257. 被引量:1
  • 3孙肖红,孙亚洲.杆状病毒表达系统及其在HPV预防疫苗研究中的应用[J].国外医学(肿瘤学分册),2001,28(2):98-100. 被引量:3
  • 4Villa LL,Costa RL,Petta CA,et al.Prophylactic quadrivalent human papillomavirus(types 6,11,16,and 18)L1 viruslike particle vaccine in young women:a randomised double-blind placebo-controlled multicentre phaseⅡefficacy trial[J].Lancet Oncol,2005,6(5):271-278. 被引量:1
  • 5Koutsky LA,Ault KA,Wheeler CM,et al.A controlled trial of a human papillomavirus type 16 vaccine[J].N Engl J Med,2002,347(21):1645-1651. 被引量:1
  • 6Cohen J.Public health.High hopes and dilemmas for a cervical cancer vaccine[J].Science,2005,308(5722):618-621. 被引量:1
  • 7Schiller JT,Davies P.Delivering on the promise:HPV vaccines and cervical cancer[J].Nat Rev Microbiol,2004,2(4):343-347. 被引量:1
  • 8Mahdavi A,Monk BJ.Vaccines against human papillomavirus and cervical cancer:promises and challenges[J].Oncologist,2005,10(7):528-538. 被引量:1
  • 9Koutsky LA,Harper DM.Chapter 13:Current findings from prophylactic HPV vaccine trials[J].Vaccine,2006,24(Suppl 3):S114一S121. 被引量:1
  • 10zur Hausen H.Papillomaviruses and cancer:from basic studies to clinical application[J].Nat Rev Cancer,2002,2(5):342-350. 被引量:1

二级参考文献25

  • 1刘宝印,李洁,De,李力,龚林,王宏,杨学志,林玉纯.我国人乳头瘤病毒58型感染与宫颈癌的关系[J].中华实验和临床病毒学杂志,1996,10(2):118-121. 被引量:15
  • 2MCCANCE D J. Human papillomaviruses and cervical cancer[J]. J Med Microbiology, 1998,47:371-373. 被引量:1
  • 3SANCLEMENTE G, GILL D K. Human papillomavirus molecular biology and pathogenesis[ J ]. J Eur Acad Dermatol Venereol, 2001,16:231-240. 被引量:1
  • 4HAGENSEE M, GALLOWEY D. Growing human papillomavirus and virus-like particles in laboratory[J]. Papillomavirus Rep, 1993,4 : 121-124. 被引量:1
  • 5CANN L, COURSAGET P, IOCHMAN S. Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells[J]. FEMS Microbiol Lett,1994,117:269-274. 被引量:1
  • 6RODEN R B, HUBBERT N L, KIRNBAUER R, et al.Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor[ J ]. J Virol, 1995,69 :5 147-5 151. 被引量:1
  • 7Kirnbauer R,Proc Nat Acad Sci USA,1992年,89卷,12180页 被引量:1
  • 8Touze A,E1 Mehdaoui S,Sizaret PY,et al.The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system[].Journal of Clinical Microbiology.1998 被引量:1
  • 9White WI,Wilson SD,Bonnez W.In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16[].Journal of Virology.1998 被引量:1
  • 10Peng S,Frazer IH,Fernando GI,et al.Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC classⅠpathway[].Journal of Virology.1998 被引量:1

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部